Mechanisms in Parkinson's Disease - Mdls., Trtmts.

00 preface_ Mechanisms in Parkinson’s Disease – Models and Treatments......Page 1
01 Update in Parkinson’s Disease......Page 23
02 Timing Control in Parkinson’s Disease......Page 61
03 Free Radicals, Oxidative Stress and
Oxidative Damage in Parkinson's Disease......Page 79
04 The Execution Step in Parkinson’s
Disease – On the Vicious Cycle of
Mitochondrial Complex I Inhibition, Iron
Dishomeostasis and Oxidative Stress......Page 101
05 Filterable Forms of Nocardia:
An Infectious Focus in the
Parkinsonian Midbrains......Page 123
06 Parkinson’s Disease and the Immune System......Page 141
07 Cyclin-Dependent Kinase 5 – An Emerging
Player in Parkinson’s Disease Pathophysiology......Page 163
08 Regulation of a-Synuclein Membrane
Binding and Its Implications......Page 179
09 Role of FKBPs in Parkinson’s Disease......Page 195
10 Targeting Tyrosine Hydroxylase
to Improve Bradykinesia......Page 211
11 Wading into a Theoretical Model
for Parkinson's Disease......Page 235
12 Successes of Modelling
Parkinson Disease in Drosophila......Page 255
13 Parkinson’s Disease and Parkin:
Insights from Park2 Knockout Mice......Page 273
14 Bilateral Distribution of Oxytocinase
Activity in the Medial Prefrontal Cortex
of Spontaneously Hypertensive Rats with
Experimental Hemiparkinsonism......Page 299
15 Dictyostelium discoideum: A Model System to
Study LRRK2-Mediated Parkinson Disease......Page 315
16 Comparison of Normal and Parkinsonian
Microcircuit Dynamics in the Rodent Striatum......Page 333
17 Animal Models of Parkinson’s Disease
Induced by Toxins and Genetic Manipulation......Page 345
18 Neuroprotective Effects
of Herbal Butanol Extracts from
Gynostemma pentaphyllum on the Exposure
to Chronic Stress in a 6-Hydroxydopamine-
Lesioned Rat Model of Parkinson's Disease
Treated with or Without L-DOPA......Page 373
19 Acetyl-L-Carnitine in Parkinson’s Disease......Page 389
20 Distribution and Regulation of the G Protein-
Coupled Receptor Gpr88 in the Striatum:
Relevance to Parkinson’s Disease......Page 415
21 Human Lymphocytes and Drosophila melanogaster as Model System to Study Oxidative Stress in Parkinson's Disease......Page 429
22 Inflammation in Parkinson’s Disease:
Causes and Consequences......Page 461
23 Neurotensin as Modulator of Basal Ganglia- Thalamocortical Motor Circuit – Emerging Evidence for Neurotensin NTS1 Receptor as a Potential Target in Parkinson's Disease......Page 493
24 Application of Embryonic Stem Cells
in Parkinson’s Disease......Page 519
25 The Role of the Neuropeptide Substance P in the Pathogenesis of Parkinson’s Disease......Page 533
26 Noradrenergic Mechanisms
in Parkinson’s Disease and
L-DOPA-Induced Dyskinesia:
Hypothesis and Evidences from
Behavioural and Biochemical Studies......Page 553
27 Mitochondrial Haplogroups
Associated with Japanese
Parkinson’s Patients......Page 579
28 Role of 123I-Metaiodobenzylguanidine
Myocardial Scintigraphy
in Parkinsonian Disorders......Page 595